Innovative Medicine
-
Young Patients To Benefit From Health Canada Approval Of Remicade®* For Treatment Of Pediatric Ulcerative Colitis
Canadian Children Six To 17 Years Old Become The First Worldwide To Benefit From A New Biologic Treatment Option Approved For Chronic Inflammatory Bowel Disease -
NUCYNTA® ER (Tapentadol Extended-Release Tablets) Receives FDA Approval For The Management Of Moderate To Severe Chronic Pain
Clinical Trial Data Demonstrate Efficacy, Safety and Favorable Tolerability -
-
Celebrity Chef Sam Talbot Joins “Life First™” Diabetes Awareness Campaign
Talbot Partners With OneTouch® Brand Blood Glucose Monitoring Systems To Help People Learn To Manage Diabetes While Living Life Without Limits -
Zytiga™* (Abiraterone Acetate) Receives Health Canada Approval For Treatment Of Metastatic Prostate Cancer
First Oral Treatment for Metastatic Prostate Cancer That Inhibits Androgen Production at All Three Sources -
Survey Finds More Than 1 In 3 Americans Have Been Personally Affected By Infections Resulting From A Hospital Stay
Innovative Technology Now Available to Disinfect Healthcare Environment, Helping Protect Patients from Environmental Pathogens -
-
-
Telaprevir Receives Positive Opinion From The Committee For Medicinal Products For Human Use (Chmp) For The Treatment Of Genotype-1 Hepatitis C Virus (HCV)
Expanding new treatment class for patients with HCV